102940.KQ
Kolon Life Science Inc.
KOE · Basic Materials · Chemicals · KR
KRW 14,560.00
−0.95%Margins
Gross margin
26.2%
EBITDA margin
17.1%
EBIT margin
16.9%
Net margin
16.4%
FCF margin
-28.0%
5.0%
Return on equity
3.2%
Return on assets
4.2%
Return on invested capital
0.19x
Asset turnover
-KRW 31.3B
Cash from operations
KRW 2.5K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026